HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Shandong Luoxin Pharmaceutical Group

16.960

-0.020-0.12%

Volume:720.00K

Turnover:12.21M

Market Cap:10.34B

PE:24.65

High:16.980

Open:16.940

Low:16.940

Close:16.980

52wk High:16.980

52wk Low:10.000

Shares:609.60M

HK Float Shares:164.56M

Volume Ratio:- -

T/O Rate:0.44%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

PS:- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Luoxin Pharmaceuticals Group Stock Co.,Ltd. (002793.SZ) Issues Positive Earnings Forecast, Expects Q1-Q3 Net Profit of 22.7-25.2 Million Yuan, Achieving Turnaround

Former Cathay Fund Manager Jiang Ying, Who Posted Losses Across 3 Products During Tenure, Transitions to Board Secretary Role at Luoxin Pharmaceuticals; Previous Secretary Earned 840,000 Yuan Annually

Luoxin Pharmaceuticals Group Appoints Jiang Ying as Board Secretary

Luoxin Pharmaceuticals Announces CFO Change: Chen Xian Resigns for Internal Transfer, Wu Yongsheng Takes Over

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/08058"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"08058","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"08058\",,,,,undefined,":{"symbol":"08058","market":"HK","secType":"STK","nameCN":"Shandong Luoxin Pharmaceutical Group","latestPrice":16.96,"timestamp":1496649585126,"preClose":16.98,"halted":4,"volume":720000,"delay":0,"floatShares":164560000,"shares":609600000,"eps":0.6880809361894165,"marketStatus":"Delisted","change":-0.02,"latestTime":"06-05 15:59:45","open":16.94,"high":16.98,"low":16.94,"amount":12209120,"amplitude":0.002356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766107800000},"marketStatusCode":0,"adr":0,"exchange":"SEHK","adjPreClose":16.98,"openAndCloseTimeList":[[1766021400000,1766030400000],[1766034000000,1766044800000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"08058\",,,,,undefined,":{"symbol":"08058","floatShares":164560000,"roa":"--","roe":"--","lyrEps":0,"shares":609600000,"dividePrice":0,"high":16.98,"amplitude":0.002356,"preClose":16.98,"low":16.94,"week52Low":10,"pbRate":"--","week52High":16.98,"institutionHeld":0,"latestPrice":16.96,"eps":0.6880809361894165,"divideRate":0,"volume":720000,"delay":0,"ttmEps":0,"open":16.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/08058\",params:#limit:5,,,undefined,":[{"date":"2017-06-16","symbol":"08058","reason":"有条件要约","type":"delisting","dateTimestamp":1497542400000},{"market":"HK","date":"2017-05-12","symbol":"08058","name":"罗欣药业","time":"","type":"earning","dateTimestamp":1494518400000,"reportTimeType":""}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"08058\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"08058\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"08058\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1150940510","title":"Luoxin Pharmaceuticals Group Stock Co.,Ltd. (002793.SZ) Issues Positive Earnings Forecast, Expects Q1-Q3 Net Profit of 22.7-25.2 Million Yuan, Achieving Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=1150940510","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150940510?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:07","pubTimestamp":1760440026,"startTime":"0","endTime":"0","summary":"Luoxin Pharmaceuticals Group Stock Co.,Ltd. (002793.SZ) disclosed its performance forecast for the first three quarters of 2025. The company expects net profit attributable to shareholders to reach...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","002793","BK0201","BK0132","08058","BK0001"],"gpt_icon":0},{"id":"1142210807","title":"Former Cathay Fund Manager Jiang Ying, Who Posted Losses Across 3 Products During Tenure, Transitions to Board Secretary Role at Luoxin Pharmaceuticals; Previous Secretary Earned 840,000 Yuan Annually","url":"https://stock-news.laohu8.com/highlight/detail?id=1142210807","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142210807?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:31","pubTimestamp":1760437862,"startTime":"0","endTime":"0","summary":"Another case has emerged of a fund manager transitioning to become a board secretary at a listed company. On October 13, Luoxin Pharmaceuticals Group Stock Co.,Ltd. (002793.SZ) announced that board...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","002793","BK0132","BK0201","BK0001","08058"],"gpt_icon":0},{"id":"1108596745","title":"Luoxin Pharmaceuticals Group Appoints Jiang Ying as Board Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1108596745","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108596745?lang=en_us&edition=fundamental","pubTime":"2025-10-13 20:51","pubTimestamp":1760359866,"startTime":"0","endTime":"0","summary":"On the evening of October 13, Luoxin Pharmaceuticals Group Stock Co.,Ltd. (002793) announced the appointment of Jiang Ying as the company's Board Secretary. The appointment aims to enhance the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08058","BK0132","002793","BK0201","BK0239","BK0001"],"gpt_icon":0},{"id":"1187480627","title":"Luoxin Pharmaceuticals Announces CFO Change: Chen Xian Resigns for Internal Transfer, Wu Yongsheng Takes Over","url":"https://stock-news.laohu8.com/highlight/detail?id=1187480627","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187480627?lang=en_us&edition=fundamental","pubTime":"2025-09-08 18:12","pubTimestamp":1757326336,"startTime":"0","endTime":"0","summary":"On September 8, Luoxin Pharmaceuticals Group Stock Co.,Ltd. (002793) announced that Chen Xian has resigned from her position as Chief Financial Officer due to work reassignment, with the resignation...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002793","BK0201","BK0239","08058","BK0132","BK0001"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/08058\",params:#limit:6,delay:false,,,undefined,":[]}}